News
Bristol-Myers takes $1.8b charge on hepatitis C drug
www.boston.com
[Boston.com] - Gilead, which spent $10.8 billion to acquire its nucleotide polymerase inhibitor, GS-7977, hasn't had the same safety issues, said Cara Miller, a company spokeswoman. “In all studies to date, GS has been well tolerated and has exhibited a
Wildwood Sounds hosts Art & Lisa
www.alamosanews.com
[Valley Courier] - Cara Miller of Radio Free Texas says, “Art and Lisa will leave an impression on your heart with their captivating songwriting and majestic vocals. They are both familiar and comfortable.” These days Art and Lisa have teamed up with legendary Texas
Google News: Clash over HIV drug's 'success'
[Mail & Guardian Online] - Gilead spokesperson Cara Miller said there are no plans to file for registration, but added: "Gilead is open and willing to discuss with international health authorities and ministries of health the potential for enabling access to Truvada for Prep
Idenix shares plunge on hepatitis C treatment heart fears
www.boston.com
[Boston.com] - Cara Miller, a spokeswoman with Foster City, California- based Gilead, and Dawn Kalmar, a spokeswoman for Cambridge, Massachusetts-based Vertex, didn't immediately respond to questions via phone and e-mail asking whether they'd been contacted by
sorted by relevance / date